Search Results - "SAWIN, H. S"

Esmolol: safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias by Schwartz, M, Michelson, E L, Sawin, H S, MacVaugh, 3rd, H

“…Esmolol, an intravenous, ultrashort-acting beta-blocker, was studied for its ability to safely control supraventricular arrhythmias up to 24 hours in 15…”
Get more information

Effects of low ionic strength solutions on pH of acid forested soils by Richter, D.D. (Duke Univ., Durham, NC), Comer, P.J, King, K.S, Sawin, H.S, Wright, D.S

“…"Salt effects" on soil pH are not well-documented with highly acidic soils in contact with solutions of very low ionic strength (less than 1 mM(c)/L). These…”
Get full text

The Program on the Surgical Control of the Hyperlipidemias: a status report by Buchwald, H, Moore, R B, Matts, J P, Long, J M, Varco, R L, Campbell, G S, Pearce, M B, Yellin, A E, Blankenhorn, D H, Holmes, W L, Smink, Jr, R D, Sawin, Jr, H S

“…The Program on Surgical Control of the Hyperlipidemias (POSCH) is a multicentered secondary coronary heart disease intervention trial utilizing maximal plasma…”
Get more information

R-wave amplitude responses to rapid atrial pacing: a marker for myocardial ischemia by David, D, Kitchen, 3rd, J G, Michelson, E L, Naito, M, Sawin, H S, Chen, C C

“…Atrial pacing-induced changes in the sum of R-wave amplitude were measured in leads V5, X, Y, and Z at rates of 100 bpm (phase I), 150 bpm (phase II), and…”
Get more information

An example of expert systems applied to clinical trials: analysis of serial graded exercise ECG test data by Long, J M, Slagle, J R, Leon, A S, Wick, M W, Matts, J P, Karnegis, J N, Bissett, J K, Sawin, H S, Stevenson, J P

“…Clinical trials collect large amounts of data over time. The use of statistical methods to compare and interpret these serial data often fall short of complete…”
Get more information

Subgroup analyses of the major clinical endpoints in the program on the surgical control of the hyperlipidemias (POSCH): Overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarction by Matts, John P, Buchwald, Henry, Fitch, Laurie L, Campos, Christian T, Varco, Richard L, Campbell, Gilbert S, Pearce, Malcolm B, Yellin, Albert E, Smink, Robert D, Sawin, Henry S, Long, John M

“…The Program on the Surgical Control of the Hyperlipidemias (POSCH) was a secondary atherosclerosis intervention trial employing partial ileal bypass surgery as…”
Get full text

Exercise cross-sectional echocardiographic diagnosis of coronary artery disease by Morganroth, Joel, Chen, Chin C., David, Daniel, Sawin, Henry S., Naito, Masahito, Parrotto, Connie, Meixell, Linda

“…To test the feasibility of detecting transient left ventricular regional wall motion abnormalities during exercise-induced myocardial ischemia, 55 patients…”
Get full text

Program on the Surgical Control of the Hyperlipidemias (POSCH): design and methodology. POSCH Group by Buchwald, H, Matts, J P, Fitch, L L, Varco, R L, Campbell, G S, Pearce, M, Yellin, A, Smink, Jr, R D, Sawin, Jr, H S, Campos, C T

“…The Program on the Surgical Control of the Hyperlipidemias (POSCH) is a prospective, randomized, controlled, multi-center, secondary, atherosclerosis…”
Get more information

Combination propranolol and bepridil therapy in stable angina pectoris by Frishman, William H., Charlap, Shlomo, Farnham, D.John, Sawin, Henry S., Michelson, Eric L., Crawford, Michael H., DiBianco, Robert, Kostis, John B., Zellner, Stephen R., Michie, David D., Katz, Richard J., Mohiuddin, Syed M., Thadani, Udho

“…The safety and efficacy of bepridil plus propranolol therapy were investigated in a placebo-controlled, parallel-design, double-blind trial in 56 patients who…”
Get full text

Changes in Sequential Coronary Arteriograms and Subsequent Coronary Events by Buchwald, Henry, Matts, John P, Fitch, Laurie L, Campos, Christian T, Sanmarco, Miguel E, Amplatz, Kurt, Castaneda-Zuniga, Wilfredo R, Hunter, David W, Pearce, Malcolm B, Bissett, Joseph K, Edmiston, W. Allan, Sawin, Henry S, Weber, Frederic J, Varco, Richard L, Campbell, Gilbert S, Yellin, Albert E, Smink, Robert D, Long, John M, Hansen, Betty J, Chalmers, Thomas C, Meier, Paul, Stamler, Jeremiah, Leon, Arthur S, Rindal, Jean, Hagen, Rebecka A, Stuenkel, Meredith R, Fujii, Dorothy C, Hatch, Julie A, Brooks, Helene B, Carins, Rebecca F, Tuna, Naip, Karnegis, James N, Stevenson, James E, Brykovsky, Regina A, Linssen, Mark A, Speech, Jane C, Castaneda, Wilfredo R, Johnson, James W, Ley, Bernie A, Bearman, Jacob E, Cooper, Gerald R, Greenhouse, Samuel W, Kennedy, J. Ward, Meinert, Curtis L, Strandness, D. Eugene, Conti, C. Richard, Titus, Jack L, Edwards, Jesse E, Griffith, Lawrence S. C, Moss, Arthur J, Spain, David M, Sanmareo, Miguel E, Blankenhorn, David H, Cashin-Hemphill, Linda, Cornfield, Jerome, Holmes, William L, Moore, Richard B, Morris, Manford D, Gotto, Antonio M, Hawkins, C. Morton, Leonard, James J, Loop, Floyd D, Rapaport, Elliot, Sylwester, David L, Tulcin, Doris, Steinberg, David, Zeppa, Robert, Casdorph, H. Richard, Van Chobanian, Aram, Scott, H. William, Hurst, J. Willis, Schlant, Robert C, Blaszkowski, Thomas P, Friedman, Lawrence M, Furberg, Curt D, Probstfield, Jeffrey L

“…Objective.—Assessment of the relationship between changes in sequential coronary arteriograms and subsequent clinical coronary events.Design.—The Program on…”
Get full text

Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias by Buchwald, H, Varco, R L, Boen, J R, Williams, S E, Hansen, B J, Campos, C T, Campbell, G S, Pearce, M B, Yellin, A E, Edmiston, W A, Smink, Jr, R D, Sawin, Jr, H S

“…In 1990, when the Program on the Surgical Control of the Hyperlipidemias (POSCH) reported its in-trial results strongly supporting the conclusion that…”
Get more information

Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) by Buchwald, Henry, Varco, Richard L, Matts, John P, Long, John M, Fitch, Laurie L, Campbell, Gilbert S, Pearce, Malcolm B, Yellin, Albert E, Edmiston, W. Allan, Smink, Robert D, Sawin, Henry S, Campos, Christian T, Hansen, Betty J, Tuna, Naip, Karnegis, James N, Sanmarco, Miguel E, Amplatz, Kurt, Castaneda-Zuniga, Wilfredo R, Hunter, David W, Bissett, Joseph K, Weber, Frederic J, Stevenson, James W, Leon, Arthur S, Chalmers, Thomas C

“…THE Program on the Surgical Control of the Hyperlipidemias (POSCH) was a multi-clinic, randomized, prospective, secondary atherosclerosis-intervention trial…”
Get full text

Subgroup analyses of the major clinical endpoints in the program on the surgical control of the hyperlipidemias (POSCH) : overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and acid mortality or myocardial infarction by MATTS, J. P, BUCHWALD, H, LONG, J. M, FITCH, L. L, CAMPOS, C. T, VARCO, R. L, CAMPBELL, G. S, PEARCE, M. B, YELLIN, A. E, SMINK, R. D, SAWIN, H. S

Get full text

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia by BUCHWALD, H, VARCO, R. L, SAWIN, H. S, CAMPOS, C. T, HANSEN, B. J, TUNA, N, KARNEGIS, J. N, SANMARCO, M. E, AMPLATZ, K, CASTANEDA-ZUNIGA, W. R, HUNTER, D. W, BISSETT, J. K, MATTS, J. P, WEBER, F. J, STEVENSON, J.W, LEON, A. S, CHALMERS, T. C, LONG, J. M, FITCH, L. L, CAMPBELL, G. S, PEARCE, M. B, YELLIN, A. E, EDMISTON, W. A, SMINK, R. D

“…Abstract Background and Methods The Program on the Surgical Control of the Hyperlipidemias (POSCH), a randomized clinical trial, was designed to test whether…”
Get full text

Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension by Michelson, E L, Frishman, W H, Lewis, J E, Edwards, W T, Flanigan, W J, Bloomfield, S S, Johnson, B F, Lucas, C, Freis, E D, Finnerty, F A

“…The long-term efficacy and safety of labetalol, an antihypertensive agent with combined beta- and alpha-blocking activity, were evaluated alone (number = 193)…”
Get more information